1. Home
  2. VVOS vs NCEL Comparison

VVOS vs NCEL Comparison

Compare VVOS & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.80

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.39

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VVOS
NCEL
Founded
2016
2008
Country
United States
Switzerland
Employees
N/A
11
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
10.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
VVOS
NCEL
Price
$0.80
$3.39
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
277.9K
64.2K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
N/A
Revenue This Year
$69.66
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.81
$1.83
52 Week High
$7.40
$5.12

Technical Indicators

Market Signals
Indicator
VVOS
NCEL
Relative Strength Index (RSI) 31.74 54.73
Support Level N/A $2.50
Resistance Level $1.50 $4.07
Average True Range (ATR) 0.11 0.44
MACD -0.03 0.10
Stochastic Oscillator 2.62 41.14

Price Performance

Historical Comparison
VVOS
NCEL

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: